Skip to content

Ultrasound and Electrophysiological Proof of the Lacertus Syndrome

Ultrasound and Electrophysiological Proof of the Lacertus Syndrome - LTS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57630
Enrollment
250
Registered
2024-11-12
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacertus syndrome, Pronator Teres syndrome, Carpal tunnel syndrome

Interventions

Lacertus surgery, ultrasound, EMG

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Presenting with median neuropathy symptoms and/or clinically suspected lacertus  syndrome.

Exclusion criteria

Exclusion criteria: Inability to provide consent, language barriers or patients in police custody 

Design outcomes

Primary

MeasureTime frame
The primary study parameters are the descriptive findings from clinical evaluation, ultrasound, and electrodiagnostic testing in patients with suspected lacertus syndrome. In patients undergoing surgery, changes in these findings will be analyzed postoperatively.

Secondary

MeasureTime frame
Secondary endpoints include improvements in: • Motor function (e.g., MRC scale, pinch strength), • Sensory function (e.g., BMRC, Semmes-Weinstein), • Patient-reported outcomes (e.g., VAS pain/function, BCTQ, EQ-5D, satisfaction, and return to work).

Countries

Netherlands

Contacts

Public ContactX Smit

Erasmus MC, Universitair Medisch Centrum Rotterdam

polikliniek.plastische@erasmusmc.nl(010) 704 01 37

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)